Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. STKE, 15 June 2004
Vol. 2004, Issue 237, p. pe25
[DOI: 10.1126/stke.2372004pe25]
PERSPECTIVES
CD40: A Growing Cytoplasmic Tale
Margaret M. Harnett
Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow G11 6NT, UK.
Summary:
CD40, a member of the tumor necrosis factor (TNF) receptor family that is expressed on B cells, monocytes, dendritic cells, endothelial cells, and epithelial cells, as well as on B cell lymphomas and carcinomas, activates multiple signaling pathways. In B cells, the response to CD40 is complex and depends on the maturation status of the cell. It is well established that CD40 can promote cell survival through up-regulation of the expression of genes encoding antiapoptotic proteins. However, a new role for CD40 signaling is being recognized in promoting progression through the cell cycle. The roles of the phosphoinositide 3-kinase, mitogen-activated protein kinase, and nuclear factor B pathways in mediating CD40 stimulation of the cell cycle are described.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
REVIEWS
Nancy Olashaw and W. J. Pledger (28 May 2002) Sci. STKE2002 (134), re7.
[DOI: 10.1126/stke.2002.134.re7] |Gloss »|Abstract »|Full Text »|PDF »
PERSPECTIVES
Juan M. Zapata and John C. Reed (21 May 2002) Sci. STKE2002 (133), pe27.
[DOI: 10.1126/stke.2002.133.pe27] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Albrecht G. von Arnim (28 August 2001) Sci. STKE2001 (97), pe2.
[DOI: 10.1126/stke.2001.97.pe2] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Bettina W. M. Richter and Colin S. Duckett (8 August 2000) Sci. STKE2000 (44), pe1.
[DOI: 10.1126/stke.2000.44.pe1] |Abstract »|Full Text »|PDF »
REVIEWS
David M. Rothwarf and Michael Karin (26 October 1999) Sci. STKE1999 (5), re1.
[DOI: 10.1126/stke.1999.5.re1] |Gloss »|Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells.
A. Zirlik, U. Bavendiek, P. Libby, L. MacFarlane, N. Gerdes, J. Jagielska, S. Ernst, M. Aikawa, H. Nakano, E. Tsitsikov, et al. (2007)
Arterioscler Thromb Vasc Biol
27, 1101-1107
|Abstract »|Full Text »|PDF »
c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient.
K. T. Lu, F. L. Sinquett, R. L. Dryer, C. Song, and L. R. Covey (2006)
Blood
108, 3769-3776
|Abstract »|Full Text »|PDF »
Key role of the p110{delta} isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110{delta} function in B cells.
A. Bilancio, K. Okkenhaug, M. Camps, J. L. Emery, T. Ruckle, C. Rommel, and B. Vanhaesebroeck (2006)
Blood
107, 642-650
|Abstract »|Full Text »|PDF »
LPS induces CD40 gene expression through the activation of NF-{kappa}B and STAT-1{alpha} in macrophages and microglia.
H. Qin, C. A. Wilson, S. J. Lee, X. Zhao, and E. N. Benveniste (2005)
Blood
106, 3114-3122
|Abstract »|Full Text »|PDF »
Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40.
C.-L. Law, K. A. Gordon, J. Collier, K. Klussman, J. A. McEarchern, C. G. Cerveny, B. J. Mixan, W. P. Lee, Z. Lin, P. Valdez, et al. (2005)
Cancer Res.
65, 8331-8338
|Abstract »|Full Text »|PDF »
Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance.
B. Huang, J. Zhao, H. Li, K.-L. He, Y. Chen, L. Mayer, J. C. Unkeless, and H. Xiong (2005)
Cancer Res.
65, 5009-5014
|Abstract »|Full Text »|PDF »